Arco-Lase Side Effects
Generic name: pancrelipase
Medically reviewed by Drugs.com. Last updated on Dec 19, 2023.
Note: This document provides detailed information about Arco-Lase Side Effects associated with pancrelipase. Some dosage forms listed on this page may not apply specifically to the brand name Arco-Lase.
Applies to pancrelipase: oral capsule, oral capsule delayed release, oral tablet, oral tablet enteric coated.
Other dosage forms:
Common side effects of Arco-Lase
Some side effects of pancrelipase may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- blurred vision
- dry mouth
- flushed, dry skin
- fruit-like breath odor
- headache
- increased hunger
- increased thirst
- increased urination
- sweating
- unexplained weight loss
- vomiting
Less common
- abnormal feces
- anxiety
- bloated feeling
- chills
- cold sweats
- confusion
- cool, pale skin
- depression
- excess air or gas in the stomach or intestines
- feeling of fullness
- fever
- frequent bowel movements
- loss of consciousness
- muscle aches
- nightmares
- passing gas
- runny nose
- seizures
- shakiness
- slurred speech
- sore throat
Incidence not known
- difficulty having a bowel movement
- difficulty with moving
- muscle aching or cramping
- muscle pains or stiffness
- muscle spasm
- swollen joints
Serious side effects of Arco-Lase
Along with its needed effects, pancrelipase (the active ingredient contained in Arco-Lase) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking pancrelipase:
Rare
- skin rash or hives
With high doses
- bowel blockage
- diarrhea
- nausea
- stomach cramps or pain
With very high doses
- blood in the urine
- joint pain
- swelling of the feet or lower legs
With powder dosage form or powder from opened capsules
- if breathed in- stuffy nose
- tightness in the chest
- trouble breathing
With tablets
- if held in the mouth- Irritation of the mouth
Incidence not known
- cough
- difficulty with swallowing
- dizziness
- fast heartbeat
- itching
- noisy breathing
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- redness of the skin
- severe stomach pain
- unusual tiredness or weakness
For healthcare professionals
Applies to pancrelipase: oral capsule, oral capsule extended release, oral delayed release capsule, oral powder for reconstitution, oral tablet, oral tablet extended release.
General
The most commonly reported side effects included gastrointestinal complaints, abdominal pain, and headaches.[Ref]
Gastrointestinal
- Very common (10% or more): Gastrointestinal complaints (up to 55%), abdominal pain (up to 18%), vomiting (up to 12%)
- Common (1% to 10%): Abdominal discomfort, abdominal distention, abdominal pain upper, abdominal tenderness, abnormal feces, anal pruritus, ascites, constipation, diarrhea, dyspepsia, early satiety, flatulence, frequent bowel movements, nausea
- Uncommon (0.1% to 1%): Bowel stricture formation
- Frequency not reported: Duodenitis, fibrosing colonopathy, gastritis, steatorrhea, strictures of the ileocecum
- Postmarketing reports: Distal intestinal obstruction syndrome (DIOS)[Ref]
Bowel stricture formation occasionally occurred in children with cystic fibrosis who received high doses.
Moderate duodenitis and gastritis occurred in a patient with exocrine pancreatic insufficiency due to cystic fibrosis 16 days after completing treatment with 4000 lipase units/gram fat ingested per day for 5 to 6 days, followed by placebo for an additional 5 to 6 days.[Ref]
Nervous system
- Very common (10% or more): Headache (up to 15%)
- Common (1% to 10%): Dizziness
- Postmarketing reports: Dull headache[Ref]
A dull headache was reported by a patient receiving treatment with ursodeoxycholic acid concomitantly. The event resolved without sequelae after discontinuation of this drug.[Ref]
Metabolic
- Common (1% to 10%): Blood cholesterol decreased, blood glucose increased, decreased appetite, diabetes mellitus, diabetes mellitus including subtypes, hyperglycemia, hypoglycemia, weight decreased
- Frequency not reported: Hyperuricemia[Ref]
Hepatic
- Common (1% to 10%): ALT increased, AST increased, biliary tract stones, blood alkaline phosphatase increased, cholangitis, GGT increased, hydrocholecystis
- Postmarketing reports: Asymptomatic liver enzyme elevations[Ref]
Hematologic
- Common (1% to 10%): Anemia, hematocrit, hemoglobin, red blood cell count, increased white blood cell count
- Frequency not reported: Transient neutropenia with/without clinical sequelae[Ref]
Respiratory
- Common (1% to 10%): Bronchitis, cough, nasopharyngitis, oropharyngeal pain, respiratory tract infection
- Postmarketing reports: Asthma[Ref]
Other
- Common (1% to 10%): Asthenia, malaise, pain, pyrexia
- Frequency not reported: Fatigue[Ref]
Dermatologic
- Common (1% to 10%): Pruritus, rash, skin reactions
- Frequency not reported: Itching, urticaria/hives
- Postmarketing reports: Blotchy/red facial rash[Ref]
Musculoskeletal
- Common (1% to 10%): Arthralgia, back pain, musculoskeletal pain
- Postmarketing reports: Muscle spasm, myalgia[Ref]
Cardiovascular
- Common (1% to 10%): Contusion, hypertension, peripheral edema[Ref]
Oncologic
- Common (1% to 10%): Metastases to specific sites, recurrent pancreatic carcinoma
- Postmarketing reports: Recurrence of preexisting carcinoma[Ref]
Psychiatric
- Common (1% to 10%): Insomnia, irritability[Ref]
Renal
- Common (1% to 10%): Renal cyst[Ref]
Immunologic
- Common (1% to 10%): Viral infection[Ref]
Hypersensitivity
- Frequency not reported: Anaphylactic reactions, hypersensitivity
- Postmarketing reports: Anaphylaxis, mild allergic reactions, severe allergic reactions[Ref]
A patient with a known history of allergy to another pancrelipase (the active ingredient contained in Arco-Lase) product developed a mild allergic reaction, including red, blotchy facial rash and itching. The event resolved without sequelae after discontinuation of this drug.[Ref]
Genitourinary
- Frequency not reported: Hyperuricosuria[Ref]
Ocular
- Postmarketing reports: Blurred vision[Ref]
References
1. (2001) "Product Information. Viokase (pancrelipase)." Wyeth-Ayerst Laboratories
2. (2022) "Product Information. Ku-Zyme (pancrelipase)." Schwarz Pharma
3. (2001) "Product Information. Zymase (pancrelipase)." Organon
4. (2001) "Product Information. Cotazym (pancrelipase)." Organon
5. (2001) "Product Information. Cotazym-S (pancrelipase)." Organon
6. (2001) "Product Information. Pancrease (pancrelipase)." McNeil Pharmaceutical
7. (2022) "Product Information. Pancrease (pancrelipase)." Apothecon Inc
8. (2001) "Product Information. Ultrase (pancrelipase)." Scandipharm Inc
9. "Product Information. Ultrase MT 12 (pancrelipase)." Scandipharm Inc
10. (2001) "Product Information. Creon 5 (pancrelipase)." Solvay Pharmaceuticals Inc
11. (2001) "Product Information. Creon 10 (pancrelipase)." Solvay Pharmaceuticals Inc
12. (2001) "Product Information. Creon 20 (pancrelipase)." Solvay Pharmaceuticals Inc
13. Cerner Multum, Inc. "Australian Product Information."
Frequently asked questions
More about Arco-Lase (pancrelipase)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: digestive enzymes
- Breastfeeding
Patient resources
Other brands
Creon, Zenpep, Pancreaze, Viokace, ... +4 more
Professional resources
Other brands
Creon, Zenpep, Pancreaze, Viokace, Pertzye
Related treatment guides
Further information
Arco-Lase side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.